IMO, there has been something wrong with GvHD. Eit

IMO, there has been something wrong with GvHD. Either the dose given wasn’t high enough or the results aren’t what NP expected. Also, GvHD isn’t a common disease so patients may be hard to recruit. NP likes to keep bad news to himself and announces good results even if it’s on 1 patient. I don’t recall NP mentioning news on the patient injected earlier this year or any patient in the past (although I’m not boned up on the GvHD trials).